Seán Crowe (Dublin South West, Sinn Fein) | Oireachtas source

Is the Health (Pricing and Supply of Medical Goods) Act 2013 a significant barrier to the approval of treatment for rare diseases given that it does not include provision for a different rule set when assessing orphan drugs?